Investigating the effect of onion extract and rosemary essential oil and caffeine on reducing hair loss in patients with androgenetic alopecia

Investigating the effect of a product containing onion extract, rosemary essential oil and caffeine on reducing hair loss in patients with mild to moderate androgenetic alopecia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150221021159N9

Enrollment

Registered

2023-10-17

Start date

2023-10-23

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia. Other androgenic alopecia

Interventions

Intervention 1: Intervention group: they are treated with the product made of onion and rosemary extract together with caffeine, twice a day. The duration of use is 12 weeks, but the treatment process

Eligibility

Sex/Gender

All

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with mild to moderate androgenetic alopecia Patients who are between 15 and 45 years old. Patients who want to participate in the study and sign the informed consent form

Exclusion criteria

Exclusion criteria: Patients with other types of alopecia Patients with psoriasis or lichen planus Patients with serious systemic disease Patients with photosensitivity Patients with the history of hair transplant Pregnant or Breast-feeding women People with onion and rosemary allergy

Design outcomes

Primary

Measure	Time frame
Hair regrowth rate. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of the study. Also, in case of desire and consent to continue the treatment after 24 weeks. Method of measurement: Handy scope fotofinder Dermoscope device.	—

Secondary

Measure	Time frame
Determination of density and thickness of hair. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of the study. Also, in case of desire and consent to continue the treatment after 24 weeks. Method of measurement: Handy scope fotofinder Dermoscope device.;Patient satisfaction. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of the study. Also, in case of desire and consent to continue the treatment after 24 weeks. Method of measurement: Handy scope fotofinder Dermoscope device.	—

Measure

Time frame

Determination of density and thickness of hair. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of the study. Also, in case of desire and consent to continue the treatment after 24 weeks. Method of measurement: Handy scope fotofinder Dermoscope device.;Patient satisfaction. Timepoint: At the beginning of the study (before the start of the intervention) and 12 weeks after the start of the study. Also, in case of desire and consent to continue the treatment after 24 weeks. Method of measurement: Handy scope fotofinder Dermoscope device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShadi Farsaei

Esfahan University of Medical Sciences

Farsaei@pharm.mui.ac+98 31 3792 7071

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026